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Background: The aim of this position statement was to inform the choice of physical activity tools for use within CF research and clinical settings.
Methods: A systematic review of physical activity tools to explore evidence for reliability, validity, and responsiveness. Narrative answers to “four
key questions” on motion sensors, questionnaires and diaries were drafted by the core writing team and then discussed at the Exercise Working
Group in ECFS Lisbon 2013.
Results and summary: Our current position is that activity monitors such as SenseWear or ActiGraph offer informed choices to facilitate a
comprehensive assessment of physical activity, and should as a minimum report on dimensions of physical activity including energy expenditure,
step count and time spent in different intensities and sedentary time. The DigiWalker pedometer offers an informed choice of a comparatively
inexpensive method of obtaining some measurement of physical activity. The HAES represents an informed choice of questionnaire to assess
physical activity. There is insufﬁcient data to recommend the use of one diary over another. Future research should focus on providing additional
evidence of clinimetric properties of these and new physical activity assessment tools, as well as further exploring the added value of physical
activity assessment in CF.
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The World Health Organisation recognises the important
role of physical activity in health and prevention of non-
communicable disease, and has published global recommen-
dations aimed at national policy makers [1]. Physical activity
has important health benefits in chronic respiratory disease
as well as in the general population. For the purposes of this
Position Statement on Physical Activity Assessment in patients
with Cystic Fibrosis (CF), physical activity is defined as “any
bodily movement produced by skeletal muscles that requires
energy expenditure” [1].
People with CF spend less time performing moderate to
vigorous intensity activity than their healthy peers and overall
physical activity in CF declines with age, similar to healthy
populations [2]. Increased activity levels have been linked to
improved fitness [3–5]. Physical fitness has been associated with
decreased mortality in CF [6–8]. Increased physical activity is
associated with a slower rate of decline in lung function in CF
[9,10] and conditioning may, at least in part, preserve lung
function [5,11–13]. Finally, high levels of physical activity have
been linked to a higher bone mineral density [14] and higher
health-related quality of life [15]. Therefore, as physical inactivity
is an important factor in the progression of morbidity and
mortality in CF and physical activity has multiple benefits, it
seems reasonable to hypothesise that there is value in assessment
of physical activity levels in people with CF.
We surveyed a convenience sample of CF centers which
primarily consisted of centers who had participated in the ECFS
Exercise Testing Consensus Survey (https://www.ecfs.eu/
ecfs_exercise_wg). The survey found that whilst physical activity
assessment was considered important, physical activity assess-
ment tools are inconsistently used in CF centers. It is important
that the physical activity tools are standardised and have good
clinimetric properties. In research this will help ensure that study
results are valid and will facilitate comparison between studies
e.g. in meta-analyses. In clinical practice this will ensure
clinicians obtain useful information about their patients as well
as inform treatment decisions on physical activity.The aim of this position statement was to inform the choice
of physical activity tools for use within CF research and clinical
settings to facilitate physical activity measurement.1.1. Methods
To achieve this aim, it was agreed that two parallel strands
of work would be conducted:1.1.1. Strand 1
Strand 1 consisted of a systematic review of the clinimetric
properties (reliability, validity, and responsiveness) of physical
activity tools using methods adopted from ECFS Research in
Nursing and Allied Health Professions Working Group and
ECFS Clinical Trials Network [16,17].
Studies on paediatric (≤12 yrs), adolescent (13–17 yrs) and
adult populations (≥18 yrs) in CF were targeted. The search
was performed from inception of the databases to December
2013. A systematic search of the following databases was
undertaken: MEDLINE, EMBASE and PubMed using relevant
search terms e.g. cystic fibrosis AND activity OR habitual
activity OR questionnaires OR motions sensors OR diaries.
A range of specific motion sensors, questionnaires and
diaries were also searched for, these included commonly
used tools and also all tools identified in the survey (more
details in the online supplementary data). “In house”
questionnaires and diaries (i.e. no published questionnaire
or diary could be sourced) were excluded from the
systematic review.
Reference lists of review articles were also reviewed to
identify any additional studies. Data that provided evidence
of clinimetric properties (reliability, validity, and respon-
siveness) of physical activity motion sensors, question-
naires and diaries are summarised in Tables 1 and 2 (full
data tables are presented in the online supplementary data).
We also explored the relationship between each physical
activity motion sensor, questionnaire/diary, and outcome
measures used in clinical practice and research.
Table 1
Studies providing evidence of clinimetric properties for motion sensors (full data tables are presented in the online supplementary data).
Reliability Convergent validity Discriminate validity Correlation with other outcomes Responsiveness
SenseWear None Evidence of correlation with indirect
calorimetry a, manual steps count a,
and the EAR monitor a [18,19]
Able to discriminate between
CF and healthy. a Within CF
able to discriminate between
exacerbation and stable
patients. a [2,20]
Evidence of significant correlation
with exercise capacity a, strength a,
bone mineral density a, kyphosis a,
and lung function a [2,20–22]
Evidence of responsiveness
to IVABa. [18,20,23]
ActiGraph Evidence of responsiveness
to IVABa. [24,25]
Evidence of correlation with the
HAES and the 7 day PAR
questionnaires and the Bratteby
activity diary a, b,c [24,25]
Within CF able to discriminate
between gender a, b, c and
disease severity b, c [15,24]
Evidence of significant correlation
with exercise capacity a, b, c [3]
Evidence of responsiveness to
a physical conditioning
program a, b, c [5]
RT3 (plus TriTrac, earlier
version of RT3)
None None [26] None TriTrac—evidence of responsiveness
to IVABb, c [27]
Caltrac Reliable over 3 points
in time b, c [28]
Evidence of correlation with the
LSI monitor b, c [28]
None None None
Large Scale Integrated Motor
Activity Monitor: LSI
Reliable over 3 points
in time b, c [28]
Evidence of correlation with
Caltrac monitor b, c[28]
None None None
e-AR None Evidence of correlation with
SenseWear a [18]
None None None
DigiWalker None None None Evidence of significant correlation
with step rate/count and respiratory
symptoms diary and lung function a, b
[29]
Evidence of responsiveness to
IVABa, b [29]
a Adults.
b Adolescents.
c Children.
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Table 2
Studies providing evidence of clinimetric properties for questionnaires and diaries (full data tables are presented in the online supplementary data).
Reliability Convergent validity Discriminate validity Correlation with other
outcomes
Responsiveness
Habitual Activity
Estimation Scale (HAES)
Reliable over two
points in time a, b, c
[25]
Evidence of correlation with activity
monitors (Sensewear and Actigraph) a, b, c
and diaries (Boucher and Bratteby) a, b, c
Significant difference between activity
in child vs. parent versions of HAES
[9,21,24,25,30]
Within CF able to discriminate
between responders and non-
responders to an exercise
programme b, c [31]
Significant correlation with
exercise capacity, body
mass and lung function b, c
[9,10,30]
Evidence of responsiveness
to training programmes b, c
[11,31]
Baecke Questionnaire None None None Evidence of significant
correlation with bone mineral
density and energy intake a
[32,33]
None
Kriska Modifiable Activity
Questionnaire
Reliable over three
points in time c [28]
Evidence of correlation with activity
monitor (Caltrac, LSI) b, c and with
physical activity questionnaire
(Harvard Alumni) b, c [28]
Able to discriminate between
CF vs healthy b, c [34]
Significant correlation with
exercise capacity and lung
function b, c [34]
None
Physical Activity Status
Questionnaire (PAS-Q)
None None Able to discriminate between
CF and healthy a Within CF
able to discriminate between
different fat free mass, different
lung function a [35–37]
Evidence of significant
correlation between lung
function a and bone mineral
density a, b [35,36,38]
None
Harvard Alumni Survey Evidence of reliability
over 3 time points c
[28]
Evidence of correlation with
activity monitors (Caltrac) b, c
and with physical activity
questionnaires (Kriska Modifiable
Activity Questionnaire) b, c [28]
None None None
Physical Activity Questionnaire
for Children (PAQ-C)
None None Able to discriminate between
CF and healthy c [39]
None None
Lipid Research Clinics
Questionnaire (LRC)
None None None Evidence of significant correlation
with exercise capacity a, b [24]
None
7-Day Physical Activity Recall
(Interview) (7-Day PAR/Five
City Project)
None Evidence of correlation
(Actigraph) a, b, c [24]
None Evidence of significant
correlation with bone mineral
density and with urinary
Pyridinium Crosslinks a [40]
None
30-day Physical Activity Recall
(Interview) (30-Day PAR)
None None Within CF able to discriminate
between gender b [41]
Significant correlation with
exercise capacity b [41]
Evidence of responsiveness to
training programme b [41]
International Physical Activity
Questionnaire (IPAQ)
None None Able to discriminate between
CF and healthy a [42]
Evidence of significant correlation
with lung function a [42]
None
Bouchard Diary None Evidence of correlation with
HAES b, c [9]
Able to discriminate between
CF and healthy b, c
Within CF able to discriminate
between CF PI and PS b [15]
Evidence of significant correlation
with exercise capacity, quality of
wellbeing and body mass
percentile a, b [15]
None
Bratteby Diary Reliable over two points
in time a, b, c [25]
Evidence of correlation with activity
monitors (Actigraph) a, b, c and
physical activity questionnaires
(HAES) a, b, c [25]
None None Responsive to inpatient
training c [43]
a Adults.
b Adolescents.
c Children.
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In strand 2 narrative answers to “four key questions” on the
use of motion sensors, questionnaires and diaries in research
and clinical practice were drafted by the core writing team and
then discussed at the Exercise Working Group in ECFS Lisbon
2013. Following feedback from the Exercise Working Group
the answers were revised and finalised:
1. Do motion sensors/questionnaires/diaries have the potential
to be used within clinical practice?
2. Do motion sensors/questionnaires/diaries have the potential
to be used as an outcome measure in research?
3. What output should be reported from motion sensors,
questionnaires and diaries?
4. What is an important treatment effect for motion sensors,
questionnaires and diaries?
A draft manuscript summarising the results of Strand 1 and 2
was circulated to the exercise working group for review and
revised until group consensus was achieved. Subsequently, the
manuscript was reviewed by the ECFS Board.
1.2. Results
1.2.1. Strand 1
Data extracted as part of this review included dimensions of
physical activity i.e. step counts, time spent being physically
active (often broken down into different intensities and different
time periods) and energy expenditure. The clinimetric properties
of physical activity assessment tools have not been evaluated
consistently between studies in CF. This makes it difficult to
compare tools or combine the results of different studies.
1.3. Motion sensors
A summary of the clinimetric properties of motion sensors
used in CF is presented in Table 1 and full data tables are
presented in the online supplementary data. A larger proportion
of motion sensor data is available in adults with CF compared
to adolescents and children. There was a general lack of
consistency between physical activity assessed by motion
sensors compared to questionnaires/diaries.
The SenseWear, ActiGraph and DigiWalker have the most
data supporting their clinimetric properties. Of these three only
the Actigraph has data on reliability. Generally for the SenseWear
and ActiGraph monitors, there is evidence of convergent validity,
i.e. correlation between these monitors and other physical activity
tools; and there is evidence of discriminate validity, i.e. these
monitors are able to discriminate between groups that are known
to differ, including CF versus healthy, between groups of people
with CF with different phenotypes or stable vs unstable states.
There has been exploration of the relationships between physical
activity with the SenseWear ActiGraph, and DigiWalker and
other clinical outcome measures in CF. There is some evidence
indicating a positive correlation between physical activity
and measures of lung function, exercise capacity, respiratory
symptoms and bone mineral density. The SenseWear, ActiGraph
and DigiWalker have data demonstrating responsiveness.1.4. Questionnaires/diaries
A summary of the clinimetric properties of physical activity
questionnaires and diaries used in CF is presented in Table 2
and ECFS website. Some studies did not provide sufficient
detail about the assessment tools evaluated (e.g. in-house
questionnaires) and these studies were excluded. For many of
the questionnaires, information has been converted into
estimates of energy expenditure (e.g. kilocalories, METs) or
some other summary measure that can be used to categorise
participants by their physical activity level. There was a general
lack of consistency between different questionnaires/diaries and
between questionnaires and monitors or diaries.
With regard to the clinimetric properties of questionnaires,
the HAES has the most available data. It has data on reliability.
There is evidence of convergent validity, i.e. correlation
between the HAES and activity monitors and diaries. and
there is evidence of discriminate validity, i.e. the HAES is able
to discriminate between groups of people with CF (responders
as and non responders to an exercise programme) There is some
evidence indicating a positive correlation between the HAES
and measures of lung function, exercise capacity, and body
mass. The HAES has data demonstrating responsiveness.
There are only two diaries, the Bouchard and the Bratteby,
each with some evidence of some clinimetric properties.
1.4.1. Strand 2
Narrative answers to the “four key questions” on motion
sensors, questionnaires and diaries were collated and are
summarised below.
1. Potential to use motion sensors, questionnaires and diaries
within clinical practice. Motion sensors, questionnaires and
diaries have the potential to be used within clinical practice;
however there are some specific considerations for each tool.
Motion sensors. An important consideration for the choice of
physical activity monitor should be the purpose for which the
data will be used. Whilst sophisticated activity monitors
eliminate the problems of subjective assessment of physical
activity (such as poor memory and biassed self-reporting),
they are more costly and analysis of data output can be a time
burden for patients and staff. Technical skills are required to
analyse and interpret the data; and use the data appropriately to
individualise physical activity advice and monitor change.
Future versions of the monitors and software may improve the
feasibility of incorporation of motion sensors into busy clinics.
Additionally many of the systems do not give direct user
feedback on current activity levels which might be important
for motivation. Pedometers offer a less costly alternative
but usually do not facilitate in-depth assessment of activity
patterns. Often simple step count may be sufficient for
assessing baseline levels of activity, monitoring change and
may also serve as a motivational tool.
Questionnaires. It is important to consider that questionnaires
measure the perception of individual physical activity, or a
caregiver-reported child's physical activity; however they do
not measure the ability of the person to be physical active, or
e30 J. Bradley et al. / Journal of Cystic Fibrosis 14 (2015) e25–e32their perceptions of symptoms during physical activity.
Questionnaires are also useful as a screening tool to identify
those that may require advice about physical activity and
facilitate discussion on physical activity patterns and goal
setting. The use of electronic scoring systems facilitates
scoring and interpretation. Questionnaires can be influenced
by many other factors and do not always relate accurately to
objective physical activity assessment. It is also not possible to
use questionnaires to provide detailed information on physical
activity levels or detect differences within individual patients
over time.
Diaries. Their use is likely to be focused on facilitating
discussion of physical activity patterns, to facilitate
self-monitoring, explore adherence, as an aide-mémoire,
as a motivational tool, and goal setting. Where possible, a
standardised diary should be used in preference to an
in-house diary. Diaries can be influenced by many other
factors particularly inaccurate completion and do not always
relate accurately to objective physical activity assessment. It is
also not possible to use diaries to provide detailed information
on physical activity levels or detect differences within
individual patients over time.
2. Potential to use motion sensors questionnaires and diaries as
outcome measures in research
Motion sensors. Motion sensors have the potential to be
used in epidemiological research and as primary endpoints
in studies investigating the efficacy of exercise/physical
activity interventions in CF. More research may need to be
conducted in CF to explore the relationship between physical
activity and true clinical endpoints (i.e. how the patient feels,
functions or survives and detection of a tangible benefit for the
patient). Establishing this link would raise the profile of
physical activity as an outcome measure in other therapeutic
trials. The use of motion sensors in multicenter clinical trials
would be facilitated by efforts towards standardisation
(e.g. agreement on most important physical activity dimen-
sions, standard operating procedures for performance of the
measurement and methods of analysis; training; central
quality control and over reading). It is also important to
achieve consensus on how to report output from motion
sensors in terms of both units and cut-off categories.
Questionnaires. Questionnaires have the potential to be used
in epidemiological research. As they have high variability they
are more suited to being secondary endpoints rather than
primary endpoints in studies investigating the efficacy of
exercise/physical activity interventions in CF.
Diaries.Wedo not recommend the use of diaries as primary or
secondary endpoints in studies investigating the efficacy of
exercise/physical activity interventions in CF. However, they
may prove to be beneficial in exploring motivation, and
adherence to the prescribed intervention
3. Reporting of outputs from motion sensors, questionnaires
and diaries.
Motion sensors. There are many aspects of physical activity
that can be measured and no single dimension comprehen-
sively captures all aspects of physical activity. In order to
expand our understanding of physical activity it would beadvantageous to report on the full range of physical activity
dimensions available with each device. At a minimum the
exercise working group propose that this should include
dimensions of physical activity including energy expendi-
ture, step count, time spent in physical activity of different
intensities, and time spent sedentary. Caution should be used
when interpreting energy expenditure data in CF. The are
some studies exploring the validity of physical activity
monitors to measure energy expenditure e.g. SenseWear
[18,19]. The algorithms used to calculate energy expenditure
assume that the energy expenditure required to perform these
activities is uniform across populations (health and disease)
and this is not the case. There is a need to establish large
data sets to support the development of energy expenditure
algorithms, and increase the accuracy of activity monitors in
energy expenditure estimation has been identified [44].
Questionnaires. There is wide variation in the outputs
available from questionnaires. Some attribute arbitrary units
of measurement to physical activity, whereas some attempt
to provide a comparative parameter such as MET-min/day.
It is important to note that the more algorithms applied to
the data the more indirect the measurement of physical
activity. This position statement is not able to provide an
answer to this as it is likely to be questionnaire-specific. We
recommend that a standardised questionnaire should be
used in preference to an in-house questionnaire.
Diaries. Some diaries attribute arbitrary units of measurement
to physical activity, whereas others attempt to classify physical
activity using a comparative parameter such as MET-min/day.
It is important to note that that the more algorithms applied to
the data the more indirect the measurement of physical
activity. This position statement is not able to provide a
specific answer to this as it is likely to be based on the rationale
for using the diary i.e. whether its use is to explore motivation,
or adherence to the prescribed intervention.
4. Consideration of an important treatment effect for motion
sensors, questionnaires and diaries
Motion sensors. Any physical activity dimension (energy
expenditure, step count, time spent in physical activity in
different intensities, time spent sedentary) will be influenced by
the device and characteristics of the specific CF population
(mild versus severe disease) and the target of the intervention.
For all the above dimensions there is no clear consensus on
what represents an important treatment effect or the likely
timeframe for change to occur. To facilitate consensus on a
clinically important difference in physical activity more
information on reliability and responsiveness is needed.
Questionnaires. This position statement is unable to answer
this. Available studies have not yet established an important
treatment effect, or the likely timeframe for change to occur
and these are likely to be questionnaire-specific.
Diaries. This question is not applicable to diaries.
2. Summary
This position statement uses the available data on clinimetric
properties to inform the current choice of physical activity
e31J. Bradley et al. / Journal of Cystic Fibrosis 14 (2015) e25–e32tools used within CF research and clinical settings to facilitate
physical activity measurement. There are several options for
both objective and subjective assessment of physical activity,
and the current position of the Exercise Working Group relating
to physical activity assessment is summarised below:
Motion sensors
• The activity monitor devices with the most available
data are SenseWear and ActiGraph. The SenseWear
and ActiGraph represent informed choices for activity
monitoring in CF. This would be in agreement with the
recommendations of the PRO-ACTIVE consortium
[45].
• For activity monitors output relating to physical activity
dimensions including energy expenditure, step count
and time spent in different intensities including seden-
tary time should be considered in order to provide a
comprehensive assessment of physical activity.
• The pedometer with the most available data in CF is
the DigiWalker. The DigiWalker currently represents
the most informed choice for a pedometer as there is
some information on the clinimetric properties.
Questionnaires
• The questionnaire with the most available data was the
HAES. The HAES currently represents an informed
choice to measure physical activity via questionnaire.
• Questionnaires are useful to screen physical activity
levels and generate discussion on physical activity
patterns.
• Questionnaires should not be used as primary outcome
measures without fully assessing their clinimetric
properties. They may be useful as a secondary outcome
measure or in larger epidemiological studies.
Diaries
• There is insufficient data to recommend the use of one
diary over another. Diaries are useful to screen physical
activity levels and generate discussion on physical
activity patterns.
3. Future research
The Exercise Working Group agreed on priority areas for
future research for physical activity assessment in CF. There is
a need to explore the clinimetric properties of current and new
technologies for the assessment of physical activity across
the age range and the disease trajectory in CF. Clinimetric
properties can differ depending on the population being studied
and it is impossible to extrapolate findings from one group of
patients to another. It is also important that when substantially
different versions of existing models of motion sensors or
software are available that research is conducted into their
clinimetric properties. Bridging studies are also required to
establish physical activity measurement as a surrogate of
treatment effects. Agreement on the optimal methods of
reporting objective physical activity data (i.e. which dimen-
sions and units) and cut-offs for categorising physical activity
intensity and daily step counts in CF are needed. The CFcommunity could refer to the methodology of other initiatives
such as the COMET (Core Outcome Measures in Effectiveness
Trials) initiative to facilitate development of “core outcome
sets” which could then be reported as a minimum in all research
on physical activity in CF, making it easier to compare or
combine results. Finally the link between physical activity and
exercise capacity in CF needs to be further explored.
Acknowledgement
This paper is an output of the ECFS Exercise Working Group
which was funded by the ECFS.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jcf.2015.05.011.
References
[1] WHO global recommendations on physical activity for health. NLM
Classification978 92 4159 9979; 2010 QT255.
[2] Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, et al.
Skeletal muscle weakness, exercise tolerance and physical activity in
adults with cystic fibrosis. Eur Respir J 2009;33:99–106.
[3] Hebestreit H, Kieser S, Rüdiger S, Schenk T, Junge S, Hebestreit A, et al.
Physical activity is independently related to aerobic capacity in cystic
fibrosis. Eur Respir J Oct 2006;28(4):734–9.
[4] Orenstein DM, Franklin BA, Doershuk CF, Hellerstein HK, Germann KJ,
Horowitz JG, et al. Exercise conditioning and cardiopulmonary fitness in
cystic fibrosis. The effects of a three-month supervised running program.
Chest Oct 1981;80(4):392–8.
[5] Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C,
et al. Long-term effects of a partially supervised conditioning programme
in cystic fibrosis. Eur Respir J Mar 2010;35(3):578–83.
[6] Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value
of exercise testing in patients with cystic fibrosis. N Engl J Med Dec 1992;
327(25):1785–8.
[7] Moorcroft AJ, Dodd ME, Webb AK. Exercise testing and prognosis in
adult cystic fibrosis. Thorax Mar 1997;52(3):291–3.
[8] Pianosi P, LeBlanc J, Almudevar A. Relationship between FEV1 and peak
oxygen uptake in children with CF. Pediatr Pulmonol 2005;40(4):324–9.
[9] Schneiderman-Walker J, Wilkes DL, Strug L, Lands LC, Pollock SL,
Selvadurai HC, et al. Sex differences in habitual physical activity and lung
function decline in children with cystic fibrosis. J Pediatr Sep 2005;
147(3):321–6.
[10] Schneiderman-Walker JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD,
Alarie N, et al. Longitudinal relationship between physical activity and lung
health in patients with cystic fibrosis. Eur Respir J 2013;43(3):817–23.
[11] Klijn PH, Oudshoorn A, van der Ent CK, van der Net J, Kimpen JL,
Helders PJ. Effects of anaerobic training in children with cystic fibrosis: a
randomized controlled study. Chest 2004;125(4):1299–305.
[12] Schneiderman-Walker J, Pollock SL, Corey M, Wilkes DD, Canny GJ,
Pedder L, et al. A randomized controlled trial of a 3-year home exercise
program in cystic fibrosis. J Pediatr Mar 2000;136(3):304–10.
[13] Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C,
et al. Effect of supervised training on FEV1 in cystic fibrosis: a
randomised controlled trial. J Cyst Fibros Dec 2013;12(6):714–20.
[14] Tejero García S, Giráldez Sánchez MA, Cejudo P, Quintana Gallego E,
Dapena J, García Jiménez R, et al. Bone health, daily physical activity, and
exercise tolerance in patients with cystic fibrosis. Chest 2011;140(2):475–81.
[15] Selvadurai HC, Blimkie CJ, Cooper PJ, Mellis CM, Van Asperen PP.
Gender differences in habitual activity in children with cystic fibrosis.
Arch Dis Child Oct 2004;89(10):928–33.
e32 J. Bradley et al. / Journal of Cystic Fibrosis 14 (2015) e25–e32[16] Bradley JM, Madge S, Morton AM, Quittner AL, Elborn JS. Cystic
fibrosis research in allied health and nursing professions. J Cyst Fibros
2012;11:387–92.
[17] De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe S, et al.
CFTR biomarkers: time for promotion to surrogate endpoint. Eur Respir J
2013;41:203–16.
[18] Weiboldt J, Atallah L, Kelly JL, Shrikrishna D, Gyi KM, Lo B, et al.
Effect of acute exacerbation on skeletal muscle strength and physical
activity in cystic fibrosis. J Cyst Fibros 2012;11(3):209–15.
[19] Dywer TJ, Alison JA, McKeough ZJ, Elkins MR, Bye PTP. Evaluation of
the SenseWear activity monitor during exercise in cystic fibrosis and in
health. Respir Med 2009;103:1511–7.
[20] Burtin C, Van Remoortel H, Vrijsen B, Langer D, Colpaert K, Gosselink
R, et al. Impact of exacerbations of cystic fibrosis on muscle strength.
Respir Res 2013;14:46.
[21] Savi D, Quattrucci S, Internullo M, De Biase RV, Calverley PMA,
Palange P. Measuring habitual physical activity in adults with cystic
fibrosis. Respir Med 2013;107:1888–94.
[22] Garcia ST, Giraldez-Sanchez MA, Cejudo P, Quintana Gallego E, Dapena
J, Garcia Jiminez R, et al. Bone health, daily physical activity and exercise
tolerance in patients with cystic fibrosis. Chest 2011;140(2):475–81.
[23] Ward N, White D, Rowe H, Stiller K, Sullivan T. Physical activity levels
of patients with cystic fibrosis hospitalised with an acute respiratory
exacerbation. Respir Med 2013;107:1014–20.
[24] Ruf KC, Fehn S, Bachmann M, Moeller A, Roth K, Kriemler S, et al.
Validation of activity questionnaires in patients with cystic fibrosis by
accelerometry and cycle-ergometry. BMC Med Res Methodol 2012;12:
43.
[25] Wells GD, Wilkes DL, Schneiderman-Walker J, Elmi M, Tullis E, Lands
LC, et al. Reliability and validity of the Habitual Activity Estimation Scale
(HAES) in patients with cystic fibrosis. Pediatr Pulmonol 2008;43(4):
345–53.
[26] Kilbride E, Widger J, Hussey J, El Nazir B, Greally P. Exercise capacity
in prepubertal children with cystic fibrosis. ISRN Pulmonol; 2012(ID
578240).
[27] Beghin L, Gottrand F, Michaud L, Vodougnon H, Wizla-Derambure N,
Hankard R, et al. Energetic costs of physical activity in children during
pseudomonas aeruginosa pulmonary exacerbation. Clin Nutr 2005;24(1):
88–96.
[28] Orenstein DM, Nixon PA, Washburn RA, Kelsey SF. Measuring physical
activity in children with cystic fibrosis: comparison of 4 methods. Pediatr
Exerc Sci 1993;5:125–33.
[29] Quon BS, Partick DL, Edwards TC, Aitken ML, Gibson RL, Genatossio
A, et al. Feasibility of using pedometers to measure daily step counts in
cystic fibrosis and an assessment of its responsiveness to changes in health
state. J Cyst Fibros 2012;11:216–22.
[30] Boucher GP, Lands LC, Hay JA, Hornby L. Activity levels and the
relationship to lung function and nutritional status in children with cystic
fibrosis. Am J Phys Med Rehabil 1997;76(4):311–5.[31] Paranjape SM, Barnes LA, Carson KA, von Berg K, Loosen H, Mogazel
PJ. Exercise improves lung function and habitual activity in children with
cystic fibrosis. J Cyst Fibros 2012;11(1):18–23.
[32] Hollander FM, de Roos NM, de Vries JHM, van Berhout FT. Assessment
of nutritional status in adult patients with cystic fibrosis: whole-body
bioimpedance vs BMI, skinfolds, and leg-to-leg bioimpedance. J Am Diet
Assoc 2005;105(4):549–54.
[33] Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, Niven R, et al.
Low bone mineral density in adults with cystic fibrosis. Thorax 1999;
54(11):961–7.
[34] Nixon PA, Orenstein DM, Kelsy SF. Habitual physical activity in children
and adolescents with cystic fibrosis. Med Sci Sports Exerc 2001;33(1):30–5.
[35] Enright S, Chatham K, Ionescu AA, Unnithan VB, Shale DJ. The influence
of body composition on respiratory muscle, lung function and diaphragm
thickness in adults with cystic fibrosis. J Cyst Fibros 2007;6(6):384–90.
[36] Ionescu A, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale DJ. Hidden
depletion of fat-free mass and bone mineral density in adults with cystic
fibrosis. Chest 2003;124:2220–8.
[37] Ionescu A, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham
K, et al. Bone density, body composition and inflammatory status in cystic
fibrosis. Am J Respir Crit Care Med 2000;162(31):789–94.
[38] Conway SP, Mortin AM, Oldroyd B, Truscott JG, White H, Slith AH,
et al. Osteoporosis and osteopenia in adults and adolescents with cystic
fibrosis: prevalence and associated factors. Thorax 2000;55(9):798–804.
[39] Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JCH, Batch J, et al.
Controlled longitudinal study of bone mass accrual in children and
adolescents with cystic fibrosis. Thorax 2006;61:146–54.
[40] Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, et al.
Vertebral deformities and low bone mineral density in adults with cystic
fibrosis: a cross-sectional study. Osteoporos Int 2001;12(5):366–72.
[41] Baker CF, Wideman L. Attitudes towards physical activity in adolescents
with cystic fibrosis: sex differences after training: a pilot study. J Pediatr
Nurs 2006;21(3):197–210.
[42] Rasekaba TM, Button BM, Wilson JW, Holland AE. Reduced physical
activity associated with work and transport in adults with cystic fibrosis. J
Cyst Fibros 2013;12(3):229–33.
[43] Selvadurai HC, Blimkie CJ, Mellis CM, Cooper PJ, van Asperen PP.
Randomized controlled study of in-hospital exercise training programs in
children with cystic fibrosis. Pediatr Pulmonol 2002;33(3):194–200.
[44] Bonomi A. Towards valid estimates of activity energy expenditure using
an accelerometer: searching for a proper analytical strategy and big data.
J Appl Physiol 2013;115(9):1227–8.
[45] Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-
Santos E, et al. Validity of activity monitors in health and chronic disease:
a systematic review. Int J Behav Nutr Phys Act 2012;9:84.
